Revance and Teoxane announce the FDA approval of RHA® Dynamic Volume from the Teoxane RHA® Collection for cheek augmentation and/or the correction of age-related midface contour deficiencies, in ...
Bayer has joined the throng of drugmakers developing KRAS-targeting therapies for cancer by licensing an early-stage candidate from Kumquat Biosciences. The deal – which has a total value of up to ...
The Trump administration has diverged from the position of former US President Joe Biden, throwing its weight behind German chemical giant Bayer in its courtroom battle over the pesticide Roundup. The ...
Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...
Seven years ago, two events set forth a domino effect culminating in Bayer leaders having a potential “tough decision” of whether or not the company will continue to manufacture its legacy herbicide ...
After launching an initial “frontrunner” a group in Illinois, Bayer says its Crop Science division is ready to roll out the company’s new operating model, Dynamic Shared Ownership (as it’s known ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback